There is a disconnect between research concerning effective treatments for substance use disorders and drug abuse treatment in community based settings. The NIDA Clinical Trial Network (CTN) proposes to bridge this gap by the partnering of academic medical centers and community treatment programs in designing and implementing clinical trials and health services research in sites spread throughout the United States. This application describes the structure, function and individuals involved in a proposed Southeastern NODE of the CTN. In the Southeastern NODE, we have assembled an experienced group of investigators with a variety of research experiences. This group has conducted single and multi-site trials in collaboration with members of the existing CTN. The participating community treatment programs are experienced, well-established programs serving diverse patient populations. Many of these programs have already worked with the researchers involved, and all are enthusiastic about the opportunities offered by the CTN.
The specific aims of this proposal are: (1) To develop an infrastructure to allow for the conduct of substance abuse research trials in the Southeastern region of the United States through a partnership with the Medical University of South Carolina and a network of community treatment programs. (2) To work collaboratively with NIDA and the other NODEs in the CTN in: a) directing at least one research trial per year investigating medications, psychosocial treatment, health services or practice research in the drug abuse area; b) participating in at least two additional research studies per year. (3) To work collaboratively with NIDA and the other CTN NODEs through the Network Steering Committee to develop and maintain the framework for the CTN including the development of operating policies and procedures, and the formation and participation in subcommittees. The CTN provides a unique and exciting opportunity to work collaboratively with colleagues from the Southeast and throughout the nation in exploring effective treatments for substance use disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
5U10DA013727-03
Application #
6523220
Study Section
Special Emphasis Panel (ZDA1-WXG-F (27))
Program Officer
Shih, Ming L
Project Start
2000-09-30
Project End
2005-08-31
Budget Start
2002-09-20
Budget End
2003-08-31
Support Year
3
Fiscal Year
2002
Total Cost
$1,800,000
Indirect Cost
Name
Medical University of South Carolina
Department
Psychiatry
Type
Schools of Medicine
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29425
Garrett, Sharon B; Doyle, Suzanne R; Peavy, K Michelle et al. (2018) Age differences in outcomes among patients in the ""Stimulant Abuser Groups to Engage in 12-Step"" (STAGE-12) intervention. J Subst Abuse Treat 84:21-29
Winhusen, Theresa; Feaster, Daniel J; Duan, Rui et al. (2018) Baseline Cigarette Smoking Status as a Predictor of Virologic Suppression and CD4 Cell Count During One-Year Follow-Up in Substance Users with Uncontrolled HIV Infection. AIDS Behav 22:2026-2032
John, William S; Zhu, He; Mannelli, Paolo et al. (2018) Prevalence, patterns, and correlates of multiple substance use disorders among adult primary care patients. Drug Alcohol Depend 187:79-87
McClure, Erin A; Baker, Nathaniel L; Sonne, Susan C et al. (2018) Tobacco use during cannabis cessation: Use patterns and impact on abstinence in a National Drug Abuse Treatment Clinical Trials Network study. Drug Alcohol Depend 192:59-66
Trivedi, Madhukar H; Greer, Tracy L; Rethorst, Chad D et al. (2017) Randomized Controlled Trial Comparing Exercise to Health Education for Stimulant Use Disorder: Results From the CTN-0037 STimulant Reduction Intervention Using Dosed Exercise (STRIDE) Study. J Clin Psychiatry 78:1075-1082
McClure, Erin A; King, Jacqueline S; Wahle, Aimee et al. (2017) Comparing adult cannabis treatment-seekers enrolled in a clinical trial with national samples of cannabis users in the United States. Drug Alcohol Depend 176:14-20
Pan, Yue; Liu, Hongmei; Metsch, Lisa R et al. (2017) Factors Associated with HIV Testing Among Participants from Substance Use Disorder Treatment Programs in the US: A Machine Learning Approach. AIDS Behav 21:534-546
Worley, Matthew J; Heinzerling, Keith G; Shoptaw, Steven et al. (2017) Volatility and change in chronic pain severity predict outcomes of treatment for prescription opioid addiction. Addiction 112:1202-1209
Babalonis, Shanna; Haney, Margaret; Malcolm, Robert J et al. (2017) Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers. Drug Alcohol Depend 172:9-13
Sherman, Brian J; McRae-Clark, Aimee L; Baker, Nathaniel L et al. (2017) Gender differences among treatment-seeking adults with cannabis use disorder: Clinical profiles of women and men enrolled in the achieving cannabis cessation-evaluating N-acetylcysteine treatment (ACCENT) study. Am J Addict 26:136-144

Showing the most recent 10 out of 142 publications